Benjamin G Feakins
Overview
Explore the profile of Benjamin G Feakins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Small S, Chan S, Walmsley R, von Fritsch L, Acquah A, Mertes G, et al.
Med Sci Sports Exerc
. 2024 May;
56(10):1945-1953.
PMID: 38768076
Purpose: Step count is an intuitive measure of physical activity frequently quantified in health-related studies; however, accurate step counting is difficult in the free-living environment, with error routinely above 20%...
2.
Small S, Chan S, Walmsley R, von Fritsch L, Acquah A, Mertes G, et al.
medRxiv
. 2023 May;
PMID: 37205346
Background: Step count is an intuitive measure of physical activity frequently quantified in a range of health-related studies; however, accurate quantification of step count can be difficult in the free-living...
3.
Oke J, Feakins B, Schlackow I, Mihaylova B, Simons C, OCallaghan C, et al.
F1000Res
. 2022 Oct;
8:1618.
PMID: 36225973
Evidence for kidney function monitoring intervals in primary care is weak, and based mainly on expert opinion. In the absence of trials of monitoring strategies, an approach combining a model...
4.
Sweeney O, Parepalli S, Mirtorabi N, Loo Yong Kee K, Feakins B, Aronson J, et al.
Pain
. 2022 Mar;
163(11):2103-2111.
PMID: 35297813
Placebos and their beneficial clinical and psychological effects are well-researched, but nocebo effects receive far less attention, despite being highly undesirable. The aim of this restricted scoping review was to...
5.
Feakins B, McFadden E, Farmer A, Stevens R
Diagn Progn Res
. 2019 May;
2:13.
PMID: 31093562
Background: Competing risks occur when populations may experience outcomes that either preclude or alter the probability of experiencing the main study outcome(s). Many standard survival analysis methods do not account...
6.
Taylor K, Verbakel J, Feakins B, Price C, Perera R, Bankhead C, et al.
BMJ
. 2018 May;
361:k1450.
PMID: 29785952
Objective: To assess the diagnostic accuracy of point-of-care natriuretic peptide tests in patients with chronic heart failure, with a focus on the ambulatory care setting. Design: Systematic review and meta-analysis....
7.
Wartolowska K, Gerry S, Feakins B, Collins G, Cook J, Judge A, et al.
Trials
. 2017 Jul;
18(1):323.
PMID: 28701195
Background: Temporal changes in the placebo arm of randomized controlled trials (RCTs) have not been thoroughly investigated, despite the fact that results of RCTs depend on the comparison between arms....
8.
Wartolowska K, Feakins B, Collins G, Cook J, Judge A, Rombach I, et al.
Trials
. 2016 Dec;
17(1):589.
PMID: 27955685
Background: Understanding changes in the placebo arm is essential for correct design and interpretation of randomized controlled trials (RCTs). It is assumed that placebo response, defined as the total improvement...
9.
Hirst J, McLellan J, Price C, English E, Feakins B, Stevens R, et al.
Clin Chem Lab Med
. 2016 Sep;
55(2):167-180.
PMID: 27658148
Background: Point-of-care (POC) devices could be used to measure hemoglobin A1c (HbA1c) in the doctors' office, allowing immediate feedback of results to patients. Reports have raised concerns about the analytical...
10.
Hirst J, Farmer A, Feakins B, Aronson J, Stevens R
Br J Clin Pharmacol
. 2014 Nov;
79(5):733-43.
PMID: 25377481
Aims: Although there are reports that β-adrenoceptor antagonists (beta-blockers) and diuretics can affect glycaemic control in people with diabetes mellitus, there is no clear information on how blood glucose concentrations...